Hexagon Capital Partners’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-19
| Closed | -$2.6K | – | 261 |
|
|
2025
Q1 | $2.6K | Sell |
19
-18
| -49% | -$2.46K | ﹤0.01% | 1333 |
|
|
2024
Q4 | $5.66K | Sell |
37
-7
| -16% | -$1.07K | ﹤0.01% | 1174 |
|
|
2024
Q3 | $8.53K | Sell |
44
-1
| -2% | -$194 | ﹤0.01% | 961 |
|
|
2024
Q2 | $10.4K | Sell |
45
-6
| -12% | -$1.39K | ﹤0.01% | 865 |
|
|
2024
Q1 | $11K | Sell |
51
-67
| -57% | -$14.4K | ﹤0.01% | 837 |
|
|
2023
Q4 | $30.5K | Buy |
118
+51
| +76% | +$13.2K | 0.01% | 523 |
|
|
2023
Q3 | $17.2K | Sell |
67
-24
| -26% | -$6.17K | ﹤0.01% | 597 |
|
|
2023
Q2 | $25.9K | Buy |
91
+3
| +3% | +$855 | 0.01% | 497 |
|
|
2023
Q1 | $24.5K | Sell |
88
-8
| -8% | -$2.22K | 0.01% | 495 |
|
|
2022
Q4 | $26.6K | Sell |
96
-89
| -48% | -$24.6K | 0.01% | 475 |
|
|
2022
Q3 | $49K | Sell |
185
-34
| -16% | -$9.01K | 0.01% | 389 |
|
|
2022
Q2 | $45K | Buy |
219
+50
| +30% | +$10.3K | 0.01% | 382 |
|
|
2022
Q1 | $36K | Sell |
169
-8
| -5% | -$1.7K | 0.01% | 411 |
|
|
2021
Q4 | $42K | Hold |
177
| – | – | 0.01% | 383 |
|
|
2021
Q3 | $50K | Hold |
177
| – | – | 0.01% | 342 |
|
|
2021
Q2 | $61K | Hold |
177
| – | – | 0.02% | 297 |
|
|
2021
Q1 | $49K | Hold |
177
| – | – | 0.01% | 309 |
|
|
2020
Q4 | $43K | Hold |
177
| – | – | 0.01% | 284 |
|
|
2020
Q3 | $44K | Buy |
+177
| New | +$44K | 0.01% | 269 |
|